Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Current Quarter	$0.12	Next Quarter	$0.12
Current Year	$0.53	Next Year	$0.48
QoQ Growth	+0.0%	YoY Growth	-9.4%
3Y EPS CAGR	-96.0%	Target Price	$9.38
Consensus	Buy	Upside	+10.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EHAB	$8.50	+4.81%	576.14K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EHAB	$8.50	+4.8%	576.14K
3
4
5
6

EHAB

EHAB

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Enhabit Inc. Data in Excel

Get Enhabit Inc. Data in Excel